Figures 11(a)–11(c) indicate that phosphorylation of AMPK/GSK3β(ser9) was decreased by 20-40% in brain extracts of 3xTg-AD mice compared to that of wild-type mice while Artemether therapy increased these phosphorylations by about 50%. Here, PRKAA1 is linked to Alzheimer disease.